Rheumatology Advisor3d
Open-Label Placebo May Reduce Chronic Low Back Pain
Open-label placebo yielded very modest analgesia in chronic low back pain, with better short- vs long-term outcomes.
News Medical on MSN2d
Open-label placebo appears to reduce premenstrual symptoms, study suggests
Women affected by premenstrual syndrome (PMS) appear to experience less intense and debilitating symptoms after taking ...
EurekAlert!3d
Open-label placebos improve premenstrual syndrome
Almost half of women of reproductive age experience complaints in the days leading up to menstruation. A lot of treatments come with side effects, only provide limited relief, or don’t work for ...
Yahoo Finance23d
Clinical Data from Open-Label DAFFODIL™ Study Evaluating Long-term Safety of DAYBUE® (trofinetide) in Patients with Rett Syndrome Published in Med
SAN DIEGO, March 05, 2025--(BUSINESS WIRE)--Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that the journal Med published results from the open-label study, DAFFODIL™, evaluating the ...
HealthDay on MSN14d
Treating Male Partners Reduces Recurrence in Bacterial Vaginosis
For heterosexual couples in which the woman has bacterial vaginosis, treating both partners makes recurrence significantly less likely.
Fierce Pharma2d
To approve Exelixis' Cabometyx in neuroendocrine tumors, FDA recognizes 'crossover impact' on survival
After canceling a planned advisory committee meeting, the FDA has approved Exelixis’ Cabometyx for neuroendocrine tumors. | ...